Randomized Study of Rivaroxaban vs Placebo on Disease Progression and Symptoms Resolution in High-Risk Adults With Mild Coronavirus Disease 2019

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 infection may be associated with a prothrombotic state, predisposing patients for a progressive disease course. We investigated whether rivaroxaban, a direct oral anticoagulant factor Xa inhibitor, would reduce coronavirus disease 2019 (COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Ananworanich, Jintanat, Mogg, Robin, Dunne, Michael W, Bassyouni, Mohamed, David, Consuela Vera, Gonzalez, Erika, Rogalski-Salter, Taryn, Shih, Heather, Silverman, Jared, Medema, Jeroen, Heaton, Penny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522357/
https://www.ncbi.nlm.nih.gov/pubmed/34523673
http://dx.doi.org/10.1093/cid/ciab813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522357/
https://www.ncbi.nlm.nih.gov/pubmed/34523673
http://dx.doi.org/10.1093/cid/ciab813

Ejemplares similares